|
|
Volumn 12, Issue 9, 2013, Pages 651-652
|
|
Patient-focused drug development programme takes first steps
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER SURVIVOR;
CHRONIC FATIGUE SYNDROME;
DATA MINING;
DRUG APPROVAL;
DRUG CONTROL;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE POLICY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LUNG CANCER;
MEDICAL DECISION MAKING;
NOTE;
OUTCOME ASSESSMENT;
PATIENT CARE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
RISK MANAGEMENT;
STUDY DESIGN;
DECISION MAKING;
DRUG APPROVAL;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
LEGISLATION, DRUG;
PATIENT ADVOCACY;
PATIENT PARTICIPATION;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84883435042
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4104 Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|
